COVID-19 is an emerging, rapidly evolving situation.
Get the latest public health information from CDC:

Get the latest research information from NIH: Menu

Individualized Adaptive De-escalated Radiotherapy for HPV-related Oropharynx Cancer

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details. Identifier: NCT03416153
Recruitment Status : Recruiting
First Posted : January 30, 2018
Last Update Posted : November 27, 2019
VA Ann Arbor Healthcare System
National Cancer Institute (NCI)
Information provided by (Responsible Party):
University of Michigan Rogel Cancer Center

No Study Results Posted on for this Study
Recruitment Status : Recruiting
Estimated Primary Completion Date : November 21, 2021
Estimated Study Completion Date : November 21, 2022